XML 77 R20.htm IDEA: XBRL DOCUMENT
v2.4.0.6

FINANCIAL INSTRUMENTS | 12 Months Ended
--- | ---
Dec. 31, 2012
FINANCIAL INSTRUMENTS [Abstract] |
FINANCIAL INSTRUMENTS | NOTE 12 - FINANCIAL INSTRUMENTS
| A. | Fair value of financial instruments:
A financial instrument is defined as cash, evidence of an ownership interest in an entity, or a contract that impose on one entity a contractual obligation either to deliver cash or receive cash or another financial instrument to or from a second entity. Examples of financial instruments include cash and cash equivalents, short-term interest-bearing bank deposits, held to maturity securities, trade accounts receivable, investments, trade accounts payable, accrued expenses, options and forward contracts. At December 31, 2012 and 2011 the fair market value of the Company's financial instruments did not materially differ from their respective book value.
| B. | Hedging activities:
The Company enters into forward contracts and currency options to hedge its balance sheet exposure as well as certain future cash flows in connection with certain operating expenses and anticipated probable transactions which are expected to be denominated in New Israeli Shekel ("NIS"). The Company is exposed to losses in the event of non-performance by counterparties to financial instruments; however, as the counterparties are major Israeli banks, for which credit risk is considered immaterial. The Company does not hold or issue derivatives for trading purposes. The notional amounts of the hedging instruments as of December 31, 2012 and December 31, 2011 were $13,284 and $8,905, respectively. The terms of all of these currency derivatives are less than one year.
| C. | Derivative Instruments
The fair value of derivative contracts as of December 31, 2011 and December 31, 2010 was as follows:
|  | Derivative Assets Reported in Other Current Assets |  |  | Derivative Liabilities Reported in Other Current Liabilities |
|  | December 31, |  |  | December 31, |
|  | 2 0 1 2 |  |  | 2 0 1 1 |  |  | 2 0 1 2 |  |  | 2 0 1 1 |
Derivatives designated as hedging instruments in cash flow hedge |  | $ | 449 |  |  | $ | - |  |  | $ | - |  |  | $ | 402 |
The following table represents the balance of derivative instruments as of December 31, 2012 and 2011, and their impact on accumulated other comprehensive income ("OCI") for the year ended December 31, 2012:
Balance at December 31,2011 |  | $ | (402 | )
Amount of loss recognized in OCI |  |  | 735 |
Amount of gain reclassified from OCI to income |  |  | 116 |
Balance at December 31,2012 |  | $ | 449 |
The impact of derivative instrument on total operating expenses in the year ended December 31, 2012, 2011 and 2010 was:
|  | Year ended December 31, |
|  | 2 0 1 2 |  |  | 2 0 1 1 |  |  | 2 0 1 0 |
Gain (loss) on derivative instruments |  | $ | (116 | ) |  | $ | 496 |  |  | $ | 113 |

X
- Definition The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures. + References No definition available. + Details
Name: | us-gaap_FinancialInstrumentsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_InvestmentsAllOtherInvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration